Addex's Dipraglurant Development in Post-Stroke Recovery Supported by Data Published in Brain

Landmark study shows mGlu5 receptor negative allosteric modulators (NAMs) restore lost neurological functionsFirst time mGlu5 linked to post-strok...

Related Keywords

Geneva ,Genè ,Switzerland ,United States ,American ,Swiss ,Tim Dyer ,Mike Sinclair ,Mikhail Kalinichev ,Janssen Pharmaceuticals Inc ,Swiss Exchange ,Nasdaq ,Hoc Announcement Pursuant ,Translational Science ,Addex Therapeutics ,Janssen Pharmaceuticals ,American Depositary Shares ,Executive Officer ,Halsin Partners ,Forward Looking Statements ,Private Securities Litigation Reform Act ,Addex Therapeutic Annual Report ,Addex Therapeutic ,